Evidence map›Paper›PMID 22132117›Full record

Trial reportPloS one2011

Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients.

Tom Bschor, Dirk Ritter, Patricia Winkelmann, Sebastian Erbe, Manfred Uhr, Marcus Ising, Ute Lewitzka

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Tom BschorDepartment of Psychiatry, Schlosspark-Clinic, Berlin, Germany. bschor@mailbox.tu-dresden.de
Dirk Ritter
Patricia Winkelmann
Sebastian Erbe
Manfred Uhr
Marcus Ising
Ute Lewitzka
Max Planck Institute of Psychiatry · DESchlosspark-Klinik · DETU Dresden · DEIzaak Walton Killam Health Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDistorted activity of the hypothalamic-pituitary-adrenocortical (HPA) system is one of the most robustly documented biological abnormalities in major depression. Lithium is central to the treatment of affective disorders, but little is known about its effects on the HPA system of depressed subjects.

objectiveTo assess the effects of lithium monotherapy on the HPA system of patients with major depression by means of the combined DEX/CRH test.

methodThirty drug-naive outpatients with major depression (single episode or unipolar recurrent; SCID I- and II-confirmed) were treated with lithium monotherapy for four weeks. The DEX/CRH test was conducted directly before intake of the first lithium tablet and four weeks thereafter. Weekly ratings with the HDRS(21) were used to determine response (≥50% symptom reduction) and remission (HDRS ≤7).

resultsLithium levels within the therapeutic range were achieved rapidly. Tolerability was good; no patient terminated the treatment prematurely. Response and remission rates were 50% and 33% respectively. Compared to the DEX/CRH test before the start of the treatment, a considerable and significant increase in all CRH-stimulated ACTH and cortisol parameters could be detected in the second DEX/CRH test. When analysed with particular regard to responders and non-responders, that significant increase was only present in the responders.

conclusionsWe were able to demonstrate that lithium leads to a significant activation of the HPA system. This is possibly connected to stimulation of hypothalamic arginine vasoporessin (AVP), to direct intracellular effects of lithium on pituitary cells and to an induction of gene expression.

trial registrationdrks-nue.uniklinik-freiburg.de DRKS00003185.

Indexed as

Corticotropin-Releasing HormoneDexamethasoneAdolescentAdrenocorticotropic HormoneAdultAgedDemographyDiagnostic Techniques and ProceduresDose-Response Relationship, DrugFemaleHumansHydrocortisoneLithiumMajor Depressive DisorderMaleMiddle AgedAdrenocorticotropic HormoneCorticotropin-Releasing HormoneDexamethasoneHydrocortisoneLithium

Identifiers

PMID22132117
PMCPMC3223180
OpenAlexW2017204557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.